CAS No – 56390-09-1

Status – Pre-Validation

Epirubicin is a chemotherapy drug, an anthracycline antibiotic, used to treat breast cancer and other malignancies. It works by inhibiting the growth of cancer cells by interfering with their DNA replication and RNA and protein synthesis. It’s typically given intravenously and can cause various side effects.